Idience Co., Ltd.
Clinical trials sponsored by Idience Co., Ltd., explained in plain language.
-
New cancer drug tested in 32 patients – early safety results
Disease control CompletedThis early-phase trial tested a new drug called NOV140101 in 32 adults with advanced solid tumors that had spread or could not be removed. The main goals were to find a safe dose and check for side effects. The study did not aim to cure the cancer, but to gather information for f…
Phase: PHASE1 • Sponsor: Idience Co., Ltd. • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New drug shows promise for Hard-to-Treat cancers with specific gene flaw
Disease control CompletedThis study tested an experimental drug called IDX-1197 in 108 adults with solid tumors that have a specific gene change (HRR mutation). The goal was to find a safe dose and see if the drug can shrink tumors. Participants had cancers that stopped responding to standard treatments …
Phase: PHASE1, PHASE2 • Sponsor: Idience Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC